# EDGAR Filing Document

**Accession Number:** 0001574094
**File Stem:** 0001493152-26-018717
**Filing Date:** 2026-4
**Character Count:** 1952
**Document Hash:** 387b4c4f743b526135b4e437863727f8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-018717.hdr.sgml**: 20260526

**ACCESSION NUMBER**: 0001493152-26-018717

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260423

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RenovoRx, Inc.
- **CENTRAL INDEX KEY:** 0001574094
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 271448452
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2570 W. EL CAMINO REAL, STE. 320,
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94040
- **BUSINESS PHONE:** 408-800-2649

**MAIL ADDRESS:**
- **STREET 1:** 2570 W. EL CAMINO REAL, STE. 320,
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94040

**RENOVORX, INC.**

2570 West El Camino Real, Suite 640

Mountain View, CA 94040

April 23, 2026

**<u>VIA EDGAR</u>**

U.S. SECURITIES AND EXCHANGE COMMISSION

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, DC 20549

Attention: Alan Campbell

Re: RenovoRx, Inc. <br> Registration Statement on Form S-3 Filed April 16, 2026 File No. 333-295108

Dear Mr. Campbell:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, RenovoRx, Inc. (the "**Company**") hereby requests acceleration of effectiveness of the above referenced Registration Statement, so that it will become effective at 4:30 p.m., Eastern time, on Monday, April 27, 2026 (the "**Effective Time**"). The Company hereby grants to Lawrence A. Rosenbloom, Esq. of Ellenoff Grossman & Schole LLP the authority to communicate to the staff of the U.S. Securities and Exchange Commission one or more requests for any potential deferral of the Effective Time.

---

| |
|:---|
| Very truly yours, |
| */s/ Shaun R. Bagai* |
| Shaun R. Bagai |
| Chief Executive Officer |

---